Canadian flagCanadian fulfilment · Free shipping $199+For laboratory research only
My account →Peptide Points →About Peptide Place →

Compound comparison

MOTS-c vs Tesamorelin: Metabolism & Visceral Fat

Published October 29, 2026

Editorial cover for MOTS-c vs Tesamorelin: Metabolism & Visceral Fat
Editorial illustration · read the original sources for evidence.

A clear comparison

MOTS-c and tesamorelin appear in metabolic discussions for different reasons. MOTS-c relates to mitochondrial signalling; tesamorelin relates to growth hormone release and visceral-fat research.

The differences at a glance

Reference facts and current product information are separate below. On a small screen, swipe within the table; keyboard users can focus it and scroll with the arrow keys.

Compare MOTS-c and Tesamorelin and Retatrutide
CompareMOTS-cTesamorelinRetatrutide
Reference · material classSingle peptideGHRH analogueSingle peptide
Reference · identity and compositionMOTS-c. Supplied form and exact specification require matching documentation.Tesamorelin. Supplied form and exact specification require matching documentation.Retatrutide. Supplied form and exact specification require matching documentation.
Reference · research questionEnergy & metabolismGrowth hormone & visceral fatWeight management
Reference · evidence and limitationsFoundational findings include cell and mouse experiments. Cellular energy research should not be read as a demonstrated improvement in everyday energy, athletic performance or weight loss in people.Visceral fat is fat around internal organs. It is different from total body weight and from the fat under the skin. Findings in people with HIV-associated abdominal fat cannot simply be extended to every weight-management question.Human trial evidence relates to specified investigational formulations and trial populations. This catalogue vial is not the trial formulation, and a larger package size does not mean a better outcome.
Reference · source papersLee et al. (2015): MOTS-c and metabolic homeostasis
Falutz et al. (2007): tesamorelin in people with HIV and abdominal fat accumulation
Jastreboff et al. (2023): phase 2 retatrutide obesity trial
Product · current sizes and prices10 mg · $79.99
In stock
20 mg · $109.00
In stock
10 mg · $109.99
In stock
20 mg · $179.99
In stock
5 mg · $69.99
In stock
10 mg · $99.99
In stock
20 mg · $179.99
In stock
Product · current stockIn stockIn stockIn stock
Product · supplied specificationConfirm form, identity and specification for the selected size. A field not reported remains unconfirmed. Product specificationsConfirm form, identity and specification for the selected size. A field not reported remains unconfirmed. Product specificationsConfirm form, identity and specification for the selected size. A field not reported remains unconfirmed. Product specifications
Product · matching lot recordsNo matching published record. Check Lab ResultsNo matching published record. Check Lab ResultsNo matching published record. Check Lab Results
Product · information and availabilityView available optionsView available optionsView available options

Product figures come from the current WooCommerce listing in the store currency. Package milligrams are nominal material amounts, not doses. No report for another sample or lot is substituted for a matching record.

Different routes through metabolism

Metabolism is the set of processes by which the body handles energy and materials. It is broad enough to include mitochondrial signalling, hormone systems and appetite-related pathways. MOTS-c and tesamorelin fit under that umbrella without acting in the same way. MOTS-c is a mitochondrial-derived peptide; tesamorelin is a growth hormone-releasing hormone analogue.

Cellular energy is not a body-weight result

Foundational MOTS-c research includes insulin-sensitivity and metabolic findings in experimental models. That is one reason it appears in energy and exercise discussions. A cellular or mouse finding should not be rewritten as proof that a person will have more energy, lose weight or improve athletic performance. The measured outcome and the study population are central to the comparison.

What visceral fat means here

Tesamorelin has been studied in people with HIV-associated abdominal fat accumulation. Visceral fat is the fat around internal organs. It is different from subcutaneous fat under the skin and from total weight on a scale. A result for one fat compartment in one clinical population does not settle every question about body composition.

Where retatrutide fits

Retatrutide is a separate metabolic comparison because it targets GIP, GLP-1 and glucagon receptors. If you arrived through a weight-loss search, read the three-way receptor comparison as well. The current table keeps catalogue sizes and prices visible, but package milligrams cannot rank different molecules by expected effect. Follow the product overviews and original sources for the fuller context.

Common questions

Is MOTS-c a GLP-1 peptide?

Its mitochondrial research background is different from the GLP-1 receptor-agonist pathway.

Are tesamorelin and retatrutide interchangeable?

No. They are different compounds with different mechanisms and study contexts.

Original sources

These papers support the specific mechanisms or study models discussed above. They do not test the current Peptide Place catalogue batches.

Continue exploring

MOTS-c: current options and full overview →

Tesamorelin: current options and full overview →

Retatrutide: current options and full overview →

Compare other peptides →

Explore this topic further

The Peptide Place Insider

Your first order.
15% better.
Get 15% off
your first order.

Your welcome code, orders and Peptide Points. One free account.

Join Insider emails and create your free Peptide Place account. Unsubscribe anytime. Adults 19+.

Privacy · Offer terms · Already joined? Sign in